Welcome to our dedicated page for Sealsq SEC filings (Ticker: LAES), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEALSQ Corp (NASDAQ: LAES) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. SEALSQ files reports on Form 6-K and uses shelf registration statements on Form F-3 and equity compensation registrations on Form S-8, as described in its submissions. These documents cover topics such as capital raises, listing changes, product milestones, and strategic collaborations related to its post-quantum semiconductor and security business.
For investors analyzing LAES, SEALSQ’s 6-K filings include information on the commercial adoption of its Quantum Shield QS7001 post-quantum secure chip and QVault TPM, preliminary unaudited revenue metrics, cash position updates, and pipeline disclosures. Other filings detail events such as the transfer of SEALSQ’s ordinary shares to The Nasdaq Global Select Market, registered direct offerings and concurrent private placements of ordinary shares and warrants, and governance changes including director resignations and senior appointments.
SEALSQ also uses 6-K exhibits to furnish press releases about strategic partnerships, joint ventures, and investments, for example its collaboration with WeCan on post-quantum KYC solutions and agreements related to a sovereign Indian post-quantum semiconductor platform. These filings are often incorporated by reference into the company’s registration statements, a fact noted within the documents themselves.
On Stock Titan, LAES filings are supplemented with AI-powered summaries that highlight key terms, structural features of offerings, and the business context of product and quantum ecosystem updates. Users can quickly locate SEALSQ’s latest 6-Ks, review historical disclosures, and connect them to related capital markets activity and technology milestones without reading every page in full.
SEALSQ Corp is relocating its Geneva headquarters to new offices at Esplanade de Pont-Rouge 4-6 in Grand-Lancy, Switzerland. The company and WISeKey SA jointly entered a commercial lease with Swiss Life AG for about 1,545 square meters of office space plus storage and parking.
The lease runs from August 1, 2026 to July 31, 2036, with a five-year renewal option and a one-time early termination right on July 31, 2031, subject to 12 months’ notice and a CHF 386,250.00 indemnity. Total annual gross rent, including ancillary costs and VAT, is approximately CHF 1,015,383.30, fully indexed to the Swiss Consumer Price Index.
The landlord granted a six-month rent-free period and a one-time tenant improvement contribution of CHF 386,250.00. A rental security deposit of CHF 504,448.65 and liability insurance coverage of CHF 8,000,000.00 are required. This information is incorporated by reference into SEALSQ’s existing Form F-3 and Form S-8 registration statements.
SEALSQ Corp filed a Form 6-K noting that it and Quobly have mutually agreed to halt discussions about a potential majority investment or acquisition of Quobly by SEALSQ. Instead, the parties plan to explore a possible minority investment once Quobly launches its Series A financing round.
The decision is presented as a shared preference for a structure that aligns better with the current pace of quantum computing investments in France. SEALSQ and Quobly will continue their existing technical and industrial collaboration, particularly focused on combining secure semiconductor technologies with scalable quantum architectures.
SEALSQ Corp has ended talks to make a majority investment or acquisition of French quantum computing company Quobly SAS and will instead consider a potential minority stake linked to Quobly’s planned Series A financing round. The shift reflects a shared view that a minority structure better matches current quantum investment dynamics in France.
SEALSQ and Quobly intend to continue their previously announced technical and industrial collaboration, focusing on combining secure semiconductor technologies with scalable quantum computing architectures. The report also highlights numerous risks and uncertainties, noting that any future investment or outcomes from the collaboration may differ materially from current expectations.
SEALSQ Corp reported strong preliminary results for FY 2025, with revenue rising 66% year over year to $18 million, signaling a shift from development to a more commercial growth phase. All figures are unaudited and final numbers are expected by March 31, 2026.
The company expects Q1 2026 revenue to exceed $4 million, more than doubling Q1 2025, helped by Vault-IC secure element demand and the full-quarter consolidation of IC’ALPS. Management reaffirmed FY 2026 guidance for revenue growth of between 50% and 100% year over year.
SEALSQ highlights more than $425 million in cash and an active business pipeline above $200 million in potential revenue from 2026 to 2028, including over $60 million tied to QS7001 and QVault TPM programs. Around $30 million was invested in 2025 to deepen vertical integration, expand smart meter and PKI recurring revenues, and advance its quantum-secure platform strategy.
SEALSQ Corp reported preliminary, unaudited 2025 results showing strong top-line growth but a larger loss. Fiscal year 2025 revenue reached $18 million, a 66% increase from 2024, with fourth quarter 2025 revenue of $8 million versus $4 million a year earlier. Growth was driven by renewed demand in core semiconductor and PKI products, about $3.5 million from five months of IC'ALPS revenue after its August 4, 2025 acquisition, and early post-quantum program traction.
The company expects a 2025 net loss between $30 million and $40 million, compared with a $21 million loss in 2024, reflecting higher R&D and sales and marketing spending, consolidation of IC'ALPS, and about $9 million of non-cash share-based compensation. As of December 31, 2025, SEALSQ held over $425 million in cash and had deployed roughly $30 million into strategic investments across semiconductor design, secure satellite communications, KYC infrastructure, and quantum chip design.
SEALSQ Corp received an updated ownership disclosure from institutional investors. CVI Investments, Inc. and Heights Capital Management, Inc. report beneficial ownership of 19,689,323 ordinary shares of SEALSQ, representing 9.9% of the class.
The reported stake consists of ordinary shares issuable upon exercise of warrants, which are subject to a 9.99% beneficial ownership limitation. Heights Capital Management acts as investment manager to CVI Investments and may be deemed to share voting and dispositive power, while both entities disclaim beneficial ownership beyond their pecuniary interest.
Susquehanna Securities, LLC reported beneficial ownership of 9,427,841 Ordinary Shares of SEALSQ Corp, representing 5.3% of the company’s Ordinary Shares. This amount includes options to buy 8,731,200 Shares, giving Susquehanna both voting and dispositive power over the reported position.
SEALSQ’s prospectus supplement indicated there were 177,400,997 Shares outstanding as of October 20, 2025; this is a baseline figure, not the amount reported in this statement. Susquehanna certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of SEALSQ.
SEALSQ Corp has entered into a non-binding memorandum of understanding to negotiate exclusively with the shareholders of Quobly SAS, a French technology company developing silicon-based quantum computers, for a potential multi-stage investment. The structure envisions SEALSQ first making a minority investment and then potentially acquiring a majority interest, under which SEALSQ would have invested approximately $200 million if a majority stake is ultimately acquired.
The potential transaction is subject to definitive agreements, due diligence, and required corporate and regulatory approvals, so there is no assurance it will close. SEALSQ also states that the information in this report is incorporated by reference into its existing Form F-3 and Form S-8 registration statements and related prospectuses.
SEALSQ Corp reported preliminary, unaudited full-year 2025 metrics showing strong top-line growth and liquidity. Revenue for 2025 is estimated at $18 million, a 66% year-on-year increase, with $8 million generated in the fourth quarter compared with $4 million in the same period a year earlier, indicating a sharp acceleration late in the year.
The company attributes this growth mainly to renewed demand for its traditional products and the consolidation of five months of revenue from IC’ALPS after its August 4, 2025 acquisition. Management notes that revenue was still adversely affected by the ongoing shift from legacy offerings to next-generation post-quantum semiconductors and software. SEALSQ also highlighted a cash position of over $425 million as of December 31, 2025, supporting its plans to advance post-quantum cryptography innovation and expand PQC-enabled semiconductor solutions, while reminding investors that these figures may change once audit and closing procedures are completed.
SEALSQ Corp reported that it has signed a non-binding Memorandum of Understanding to enter exclusive negotiations for a strategic investment in French quantum computing firm Quobly. The contemplated multi-stage deal would start with a minority stake and could lead to SEALSQ acquiring a majority interest in Quobly, with a potential total investment of approximately $200M, all subject to definitive agreements, due diligence, approvals, and customary conditions.
Quobly develops silicon-based quantum processors using established semiconductor manufacturing processes, and already works with SEALSQ under an existing collaboration. The proposed transaction fits within SEALSQ’s quantum strategy and its dedicated Quantum Fund, aiming to build secure-by-design, post-quantum-ready computing platforms for sectors such as defense, intelligence, financial services, and pharmaceuticals.